SEC Form 4 · accession 0000899243-18-030791
Akebia Therapeutics, Inc. · AKBA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P. Butler
Officer — CEO & President · Director
Period of report
Dec 12, 2018
Accepted (ET)
Dec 13, 2018 · 8:10 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001517022
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2018 | F | 135,697 | $8.94 | D | 374,617 | D | |
| Common Stock | holding | — | — | — | 31,047 | I | Held by Dorothy Butler 2016 GRAT | |
| Common Stock | holding | — | — | — | 31,047 | I | Held by John Butler 2016 GRAT | |
| Common Stock | holding | — | — | — | 27,353 | I | Held by Dorothy Butler Revocable Trust November 20, 2007 | |
| Common Stock | holding | — | — | — | 27,353 | I | Held by John P. Butler Revocable Trust November 20, 2007 |
Table II — derivative securities
No Table II lines on this filing.